Year archive

Vaxcell-Bio Therapeutics — 2023 filings

All 53 regulatory filings released by Vaxcell-Bio Therapeutics (323990) in 2023, sourced directly from the official regulator.

53 Filings

2023 Period

2023 filings (53)

Filing	Released	Lang
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-12-13	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-12-13	Korean
주주명부폐쇄기간또는기준일설정 Notice of Dividend Amount	2023-12-12	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2023-11-17	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-11-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-11-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-11-16	Korean
분기보고서 (2023.09) Interim / Quarterly Report 9M 2023	2023-11-13	Korean
증권발행결과(자율공시)(주주배정 후 실권주 일반공모 유상증자) Share Issue/Capital Change	2023-11-09	Korean
증권발행실적보고서 Capital/Financing Update	2023-11-09	Korean
권리락(무상증자) Share Issue/Capital Change	2023-11-09	Korean
유상증자또는주식관련사채등의청약결과(자율공시) Share Issue/Capital Change	2023-11-08	Korean
유상증자또는주식관련사채등의청약결과(자율공시) Capital/Financing Update	2023-11-03	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2023-10-31	Korean
유상증자최종발행가액확정(주주배정 후 실권주 일반공모) Capital/Financing Update	2023-10-30	Korean
[발행조건확정]증권신고서(지분증권) Share Issue/Capital Change	2023-10-30	Korean
[기재정정]주요사항보고서(유무상증자결정) Share Issue/Capital Change	2023-10-30	Korean
[기재정정]투자설명서 Capital/Financing Update	2023-10-30	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-10-23	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-10-23	Korean
투자판단관련주요경영사항(유선종양에 이환된 개에서 수술 후 적용하는 항암병용치료제(Vaxleukin-15 inj.) 품목허가 신청) Regulatory Filings	2023-10-23	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2023-10-23	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-10-13	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-10-13	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2023-10-06	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-09-26	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2023-09-26	Korean
[기재정정]증권신고서(지분증권) (2023.10) Share Issue/Capital Change	2023-09-26	Korean
[기재정정]투자설명서 Investor Presentation	2023-09-26	Korean
유상증자1차발행가액결정 Capital/Financing Update	2023-09-19	Korean
[발행조건확정]증권신고서(지분증권) Share Issue/Capital Change	2023-09-19	Korean
[기재정정]주요사항보고서(유무상증자결정) Share Issue/Capital Change	2023-09-19	Korean
[기재정정]투자설명서 Capital/Financing Update	2023-09-19	Korean
권리락(유상증자) Share Issue/Capital Change	2023-09-19	Korean
투자설명서 Capital/Financing Update	2023-09-06	Korean
[기재정정]증권신고서(지분증권) (2023.10) Share Issue/Capital Change	2023-09-04	Korean
[기재정정]증권신고서(지분증권) (2023.10) Capital/Financing Update	2023-08-21	Korean
반기보고서 (2023.06) Interim / Quarterly Report H1 2023	2023-08-14	Korean
주권매매거래정지(무상증자) Share Issue/Capital Change	2023-08-07	Korean
주요사항보고서(유무상증자결정) Share Issue/Capital Change	2023-08-07	Korean
증권신고서(지분증권) (2023.10) Share Issue/Capital Change	2023-08-07	Korean
투자판단관련주요경영사항(임상시험계획변경승인신청)(진행성 췌장암 환자에서 자연살해세포와 mFOLFIRINOX 병합치료의 임상 2a상 연구) Regulatory Filings	2023-07-31	Korean
분기보고서 (2023.03) Interim / Quarterly Report Q1 2023	2023-05-12	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2023-03-24	Korean
감사보고서제출 Audit Report / Information FY 2022	2023-03-15	Korean
사업보고서 (2022.12) Annual Report FY 2022	2023-03-15	Korean
[기재정정]주주총회소집공고 Proxy Solicitation & Information Statement	2023-03-13	Korean
주주총회소집결의 AGM Information	2023-03-08	Korean
주주총회소집공고 AGM Information	2023-03-08	Korean
주주총회집중일개최사유신고 AGM Information	2023-03-08	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2022	2023-02-23	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2023-02-23	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2023-02-07	Korean